Literature DB >> 11598879

Heat-induced formation of a specific binding site for self-assembled Congo Red in the V domain of immunoglobulin L chain lambda.

B Piekarska1, L Konieczny, J Rybarska, B Stopa, G Zemanek, E Szneler, M Król, M Nowak, I Roterman.   

Abstract

Moderate heating (40-50 degrees C) of immunoglobulins makes them accessible for binding with Congo Red and some related highly associated dyes. The binding is specific and involves supramolecular dye ligands presenting ribbon-like micellar bodies. The L chain lambda dimer, which upon heating disclosed the same binding requirement with respect to supramolecular dye ligands, was used in this work to identify the site of their attachment. Two clearly defined dye-protein (L lambda chain) complexes arise upon heating, here called complex I and complex II. The first is formed at low temperatures (up to 40-45 degrees C) and hence by a still native protein, while the formation of the second one is associated with domain melting above 55 degrees C. They contain 4 and 8 dye molecules bound per L chain monomer, respectively. Complex I also forms efficiently at high dye concentration even at ambient temperature. Complex I and its formation was the object of the present studies. Three structural events that could make the protein accessible to penetration by the large dye ligand were considered to occur in L chains upon heating: local polypeptide chain destabilization, VL-VL domain incoherence, and protein melting. Of these three possibilities, local low-energy structural alteration was found to correlate best with the formation of complex I. It was identified as decreased packing stability of the N-terminal polypeptide chain fragment, which as a result made the V domain accessible for dye penetration. The 19-amino acid N-terminal fragment becomes susceptible to proteolytic cleavage after being replaced by the dye at its packing locus. Its splitting from the dye-protein complex was proved by amino acid sequence analysis. The emptied packing locus, which becomes the site that holds the dye, is bordered by strands of amino acids numbered 74-80 and 105-110, as shown by model analysis. The character of the temperature-induced local polypeptide chain destabilization and its possible role in intramolecular antibody signaling is discussed. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598879     DOI: 10.1002/1097-0282(200111)59:6<446::AID-BIP1049>3.0.CO;2-X

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  5 in total

1.  Analysis of the effect of electrostatic energy truncation in molecular dynamics simulations of immunoglobulin G light chain dimer.

Authors:  Marcin Król
Journal:  J Mol Model       Date:  2003-07-24       Impact factor: 1.810

2.  Influence of the electric field on supramolecular structure and properties of amyloid-specific reagent Congo red.

Authors:  Paweł Spólnik; Marcin Król; Barbara Stopa; Leszek Konieczny; Barbara Piekarska; Janina Rybarska; Grzegorz Zemanek; Anna Jagusiak; Piotr Piwowar; Grzegorz Szoniec; Irena Roterman
Journal:  Eur Biophys J       Date:  2011-09-24       Impact factor: 1.733

Review 3.  Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool.

Authors:  A Jagusiak; L Konieczny; M Krol; P Marszalek; B Piekarska; P Piwowar; I Roterman; J Rybarska; B Stopa; G Zemanek
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

4.  The use of supramolecular structures as protein ligands.

Authors:  Barbara Stopa; Anna Jagusiak; Leszek Konieczny; Barbara Piekarska; Janina Rybarska; Grzegorz Zemanek; Marcin Król; Piotr Piwowar; Irena Roterman
Journal:  J Mol Model       Date:  2013-01-08       Impact factor: 1.810

5.  Interaction of Supramolecular Congo Red and Congo Red-Doxorubicin Complexes with Proteins for Drug Carrier Design.

Authors:  Anna Jagusiak; Katarzyna Chłopaś; Grzegorz Zemanek; Izabela Kościk; Irena Roterman
Journal:  Pharmaceutics       Date:  2021-11-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.